The FDA gave Antigenics Inc. the go-ahead to resume enrollment of two Phase III trials for the personalized cancer vaccine Oncophage, following a 13-week partial clinical hold. (BioWorld Today)

WASHINGTON - Medicare legislation poised for a vote in Congress contains language designed to get generics to market faster by closing loopholes in a law that has enabled certain innovator pharmaceutical companies to block generic competition. (BioWorld Today)